Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Taxotere monotherapy in high-risk metastatic prostate cancer
2004-004874-96Phase 2Completed
- Sponsor
- Newcastle Hospitals NHS Foundation Trust
- Start
- Jul 2005
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of docetaxel in prostate cancer (PCa), sponsored by Newcastle Hospitals NHS Foundation Trust. Primary endpoints: Response rate and Time to progression. Started Jul 2005; status: completed.
02
Drugs
docetaxel
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on 2004-004874-96.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-004874-96.